Acetyl-L-carnitine in hepatic encephalopathy

Metabolic Brain Disease

Volumn 28, Issue 2, 2013, Pages 193-199

  Malaguarnera, Michele ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acetyl L carnitine; Ammonia; Cirrhosis; Hepatic encephalopathy; L carnitine

Indexed keywords

AMMONIA; FREE RADICAL; GLUTAMATE RECEPTOR; LEVACECARNINE; ACETYLCARNITINE;

AMMONIA BLOOD LEVEL; ASTROCYTE; ATTENTION; CELL ORGANELLE; CELL SWELLING; COGNITIVE DEFECT; COMA; CONFERENCE PAPER; CONSENSUS; DEPRESSION; DISEASE SEVERITY; DISORIENTATION; DYSTHYMIA; ENZYME ACTIVATION; FATIGUE; FLAPPING TREMOR; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; HYPERREFLEXIA; INFLAMMATION; LANGUAGE; MEMORY DISORDER; MENTAL CONCENTRATION; MENTAL DEFICIENCY; MENTAL DETERIORATION; MITOCHONDRION; MOTOR PERFORMANCE; MYOCLONUS; PATHOGENESIS; PEROXISOME; PSYCHOMOTOR ACTIVITY; PSYCHOMOTOR DISORDER; QUALITY OF LIFE; REACTION TIME; RIGIDITY; SENSORY DYSFUNCTION; SHORT TERM MEMORY; UREA CYCLE; ANIMAL; CLASSIFICATION; COMPLICATION; METABOLISM;

ACETYLCARNITINE; ANIMALS; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA;

EID: 84878016950     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-013-9376-4     Document Type: Conference Paper

References (28)

1. Aureli T, Di Cocco ME, Puccetti C, Ricciolini R, Scalibastri M, Miccheli A, Manetti C, Conti F (1998) Acetyl-Lcarnitine modulates glucose metabolism and stimulates glycogen synthesis in rat brain. Brain Res 796(1-2):75-81. doi: 10.1016/S0006-8993(98)00319-9
2. Cauli O, Rodrigo R, Llansola M, Montoliu C, Monfort P, Piedrafita B, El Mlili N, Boix J, Agustí A, Felipo V (2009) Glutamatergic and gabaergic neurotransmission and neuronal circuits in hepatic encephalopathy. Metab Brain Dis 24(1):69-80. doi: 10.1007/s11011-008-9115-4
3. Di Cesare Mannelli L, Ghelardini C, Toscano A, Pacini A, Bartolini A (2010) The neuropathy-protective agent acetylL-carnitine activates protein kinase C-gamma and MAPKs in a rat model of neuropathic pain. Neuroscience 165(4):1345-1352. doi: 10.1016/j.neuroscience.2009.11.021
4. Fiskum G, Rosenthal RE, Vereczki V, Martin E, Hoffman GE, Chinopoulos C, Kowaltowski A (2004) Protection against ischemic brain injury by inhibition of mitochondrial oxidative stress. J Bioenerg Biomembr 36(4):347-352. doi: 10.1023/B:JOBB.0000041766.71376.81
5. Flanagan JL, Simmons PA, Vehige J, Willcox MD, Garrett Q (2010) Role of carnitine in disease. Nutr Metab (Lond) 7:30. doi: 10.1186/1743-7075-7-30
6. Jones EA, Mullen KD (2012) Theories of the pathogenesis of hepatic encephalopathy. Clin Liver Dis 16(1):7-26. doi: 10.1016/j.cld.2011.12.010
7. Limketkai BN, Zucker SD (2008) Hyperammonemic encephalopathy caused by carnitine deficiency. J Gen Intern Med 23:210-213. doi: 10.1007/s11606-007-0473- 0
8. Llansola M, Erceg S, Hernández-Viadel M, Felipo V (2002) Prevention of ammonia and glutamate neurotoxicity by carnitine: molecular mechanisms. Metab Brain Dis 17(4):389-397. doi: 10.1023/A:1021922305036
9. Malaguarnera M, Pistone G, Astuto M, Vecchio I, Raffaele R, Lo Giudice E, Rampello L (2006) Effects of Lacetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial. Dig Dis Sci 51(12):2242-2247. doi: 10.1007/s10620-006-9187-0
10. Malaguarnera M, Gargante MP, Cristaldi E, Vacante M, Risino C, Cammalleri L, Pennisi G, Rampello L (2008) Acetyl-L-carnitine treatment in minimal hepatic encephalopathy. Dig Dis Sci 53(11):3018-3025. doi: 10.1007/s10620-008-0238-6
11. Malaguarnera M, Risino C, Cammalleri L, Malaguarnera L, Astuto M, Vecchio I, Rampello L (2009) Branched chain amino acids supplemented with L-acetyl carniti ne versus BCAA treatment in hepatic coma: a randomized and controlled double blind study. Eur J Gastroenterol Hepatol 21(7):762-770. doi: 10.1097/MEG.0b013e328309c791
12. Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Motta M, Mistretta A, Rampello L, Pennisi G (2011a) Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol 46(6):750-759. doi: 10.3109/00365521. 2011.565067
13. Malaguarnera M, Vacante M, Giordano M, Pennisi G, Bella R, Rampello L, Malaguarnera M, Li Volti G, Galvano F (2011b) Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 93(4):799-808. doi: 10.3945/ajcn.110.007393
14. Malaguarnera M, Vacante M, Motta M, Giordano M, Malaguarnera G, Bella R, Nunnari G, Rampello L, Pennisi G (2011c) Acetyl-L-carniti ne improves cognitive functions in severe hepatic encephal opathy: a randomized and controlled clinical trial. Metab Brain Dis 26(4):281-289. doi: 10.1007/s11011-011-9260-z
15. Malaguarnera M, Vacante M, Giordano M, Motta M, Bertino G, Pennisi M, Neri S, Malaguarnera M, Li Volti G, Galvano F (2011d) L-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-a 2b plus ribavirin. World J Gastroenterol 17(39):4414-4420. doi: 10.3748/wjg.v17.i39.4414
16. Matsuda I, Ohtani Y (1986) Carnitine status in Reye and Reye-like syndromes. Pediatr Neurol 2(2):90-94
17. McPhail MJ, Bajaj JS, Thomas HC, Taylor-Robinson SD (2010) Pathogenesis and diagnosis of hepatic encephalopathy. Expert Rev Gastroenterol Hepatol 4(3):365-378. doi: 10.1586/egh.10.32
18. Miñana MD, Hermenegildo C, Llsansola M, Montoliu C, Grisolía S, Felipo V (1996) Carnitine and choline derivatives containing a trimethylamine group prevent ammonia toxicity in mice and glutamate toxicity in primary cultures of neurons. J Pharmacol Exp Ther 279(1):194-199
19. Norenberg MD, Jayakumar AR, Rama Rao KV (2004) Oxidative stress in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 19(3-4):313-329. doi: 10.1023/B:MEBR.0000043978.91675.79
20. Peluso G, Barbarisi A, Savica V, Reda E, Nicolai R, Benatti P, Calvani M (2000) Carnitine: an osmolyte that plays a metabolic role. J Cell Biochem 80(1):1-10. doi: 10.1002/1097-4644(20010101)
21. Rama Rao KV, Norenberg MD (2012) Brain energy metabolism and mitochondrial dysfunction in acute and chronic hepatic encephalopathy. Neurochem Int 60(7):697-706. doi: 10.1016/j.neuint.2011.09.007
22. Rama Rao KV, Jayakumar AR, Norenberg MD (2012) Glutamine in the pathogenesis of acute hepatic encephalopathy. Neurochem Int. doi: 10.1016/j.neuint.2012.01.012
23. Ratnakumari L, Qureshi IA, Butterworth RF (1993) Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy. Metabolism 42(8):1039-1046. doi: 10.1016/0026-0495(93)90020-O
24. Rebouche CJ (1992) Carnitine function and requirements during the life cycle. FASEB J 6(15):3379-3386
25. Rodrigo R, Cauli O, Boix J, ElMlili N, Agusti A, Felipo V (2009) Role of NMDA receptors in acute liver failure and ammonia toxicity: therapeutical implications. Neurochem Int 55(1-3):113-118. doi: 10.1016/j.neuint.2009.01.007
26. Rose C, Felipo V (2005) Limited capacity for ammonia removal by brain in chronic liver failure: potential role of nitric oxide. Metab Brain Dis 20(4):275-283. doi: 10.1007/s11011-005-7906-4
27. Scafidi S, Fiskum G, Lindauer SL, Bamford P, Shi D, Hopkins I, McKenna MC (2010) Metabolism of acetyl-Lcarnitine for energy and neurotransmitter synthesis in the immature rat brain. J Neurochem 114(3):820-831. doi: 10.1111/j.1471-4159.2010.06807.x
28. Therrien G, Rose C, Butterworth J, Butterworth RF (1997) Protective effect of L-carnitine in ammonia-precipitated encephalopathy in the portacaval shunted rat. Hepatology 25(3):551-556. doi: 10.1002/hep.510250310